These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3205172)

  • 61. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Mentel R
    Kinderarztl Prax; 1993 Aug; 61(6):227-8. PubMed ID: 8105135
    [No Abstract]   [Full Text] [Related]  

  • 62. Adverse events temporally associated with immunizing agents--1987 report.
    Koch J; Leet C; McCarthy R; Carter A; Cuff W
    Can Dis Wkly Rep; 1989 Jul; 15(30):151-8. PubMed ID: 2788525
    [No Abstract]   [Full Text] [Related]  

  • 63. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland.
    Pebody RG; Paunio M; Ruutu P
    BMJ; 1998 Jun; 316(7146):1745-6. PubMed ID: 9652932
    [No Abstract]   [Full Text] [Related]  

  • 64. Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?
    Amin J; McIntyre PB; Heath TC
    Commun Dis Intell; 1998 Apr; 22(4):58-9. PubMed ID: 9616048
    [No Abstract]   [Full Text] [Related]  

  • 65. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children.
    Miller E; Goldacre M; Pugh S; Colville A; Farrington P; Flower A; Nash J; MacFarlane L; Tettmar R
    Lancet; 1993 Apr; 341(8851):979-82. PubMed ID: 8096942
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M; Berger R; Glück R; Wegmann A
    Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MMR vaccine: a new initiative.
    Miller C
    Practitioner; 1989 Jan; 233(1461):63-4, 66. PubMed ID: 2798287
    [No Abstract]   [Full Text] [Related]  

  • 68. Mumps vaccines--current status.
    Forsey T
    J Med Microbiol; 1994 Jul; 41(1):1-2. PubMed ID: 8006938
    [No Abstract]   [Full Text] [Related]  

  • 69. Autism, inflammatory bowel disease, and MMR vaccine.
    Bhatt R
    Lancet; 1998 May; 351(9112):1357. PubMed ID: 9643820
    [No Abstract]   [Full Text] [Related]  

  • 70. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.
    Vlacha V; Forman EN; Miron D; Peter G
    Pediatrics; 1996 May; 97(5):738-9. PubMed ID: 8628619
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of measles-mumps-rubella vaccination on polymorphonuclear neutrophil functions in children.
    Toraldo R; Tolone C; Catalanotti P; Ianniello R; D'Avanzo M; Canino G; Galdiero F; Iafusco F
    Acta Paediatr; 1992 Nov; 81(11):887-90. PubMed ID: 1467611
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
    Amin J; Wong M
    Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836
    [No Abstract]   [Full Text] [Related]  

  • 73. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
    MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Side effects of the use of the preventive mixed mumps, rubella and measles vaccine inchildren of the City of São Paulo].
    Konichi SR; Laus WC; Mattos CA; Amato Neto V; Aly J; Finger H; Bianchi A
    Rev Inst Med Trop Sao Paulo; 1973; 15(3):161-4. PubMed ID: 4732747
    [No Abstract]   [Full Text] [Related]  

  • 75. Mumps vaccination and meningitis.
    Peltola H
    Lancet; 1993 Apr; 341(8851):994-5. PubMed ID: 8096949
    [No Abstract]   [Full Text] [Related]  

  • 76. MMR vaccine and neomycin allergy.
    Kwittken PL; Rosen S; Sweinberg SK
    Am J Dis Child; 1993 Feb; 147(2):128-9. PubMed ID: 8427228
    [No Abstract]   [Full Text] [Related]  

  • 77. Adverse events following measles-mumps-rubella and measles vaccinations in college students.
    Chen RT; Moses JM; Markowitz LE; Orenstein WA
    Vaccine; 1991 May; 9(5):297-9. PubMed ID: 1872012
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Measles, mumps, rubella and the GP.
    Kerrigan P
    Practitioner; 1988 Oct; 232(1456 ( Pt 2)):1121. PubMed ID: 3256857
    [No Abstract]   [Full Text] [Related]  

  • 79. Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization.
    Drachtman RA; Murphy S; Ettinger LJ
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):326-7. PubMed ID: 8130872
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease.
    McDonald JC; Moore DL; Quennec P
    Pediatr Infect Dis J; 1989 Nov; 8(11):751-5. PubMed ID: 2594449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.